G21.1
Other drug-induced secondary parkinsonism
Clinical Classification Guidelines
Medical Intelligence & Overview
Other drug-induced secondary parkinsonism is a condition characterized by Parkinson's-like symptoms resulting from the use of certain medications. Unlike idiopathic Parkinson's disease, this form of parkinsonism is directly linked to medication side effects, often resolving once the offending drug is discontinued. Recognizing this condition is important for proper management and to differentiate it from primary Parkinson's disease.
Causes & Symptoms
Clinical Causes: Use of neuroleptic or antipsychotic medications Certain antidepressants Anti-nausea drugs, such as metoclopramide Calcium channel blockers Other drugs affecting dopamine pathways
Key Symptoms: Resting tremor, often starting in one hand Muscle rigidity or stiffness Bradykinesia or slowed movement Postural instability or impaired balance Masked facial expression Reduced arm swing during walking Shuffling gait Difficulty initiating movements
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough review of the patient's medical history, including recent or ongoing medications known to cause parkinsonian symptoms. A neurological examination assesses motor symptoms, while imaging tests like MRI or DaTscan may be used to exclude other causes. Importantly, observing symptom improvement after stopping the suspected medication can aid in confirming drug-induced parkinsonism.
Treatment Protocols: Treatment primarily focuses on discontinuing or substituting the medication responsible for symptoms. In some cases, symptoms may improve within weeks to months. Symptomatic treatments such as physiotherapy, and in certain circumstances, medications like amantadine, might be used to manage persistent symptoms, but careful evaluation is necessary. Follow-up assessments are essential to monitor recovery and manage any ongoing issues.
Clinical Advice & FAQs
Billing Guidance
Is G21.1 a billable ICD-10 code?
Yes, G21.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G21.1?
Clinical documentation must specify the nature of Other drug-induced secondary parkinsonism and any associated comorbidities for accurate reporting.
Cite this Clinical Reference